This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Wearable Technology: The proliferation of wearable devices is enabling continuous health monitoring and remote patient care, creating new market opportunities. Regulatory Landscape: Regulatory Clarity: Clearer regulatory frameworks for digital healthtechnologies will foster investor confidence and higher valuations.
Regulatory Landscape: Changes in regulatory frameworks, such as the easing of restrictions on telehealth, will create new opportunities for M&A. The increasing adoption of digital healthtechnologies, the growing importance of AI and ML, and the evolving regulatory landscape will continue to shape the deal landscape.
In 2025, B2C2B models are poised to become increasingly prominent in healthcare, driven by several key factors: Digital Health Boom: The rapid growth of digital healthtechnologies, such as telehealth, wearable devices, and AI-powered diagnostics, is creating new opportunities for B2C2B companies to reach both patients and healthcare providers.
We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions.”
Blockchain can also ensure the accuracy of the data exchanged among entities, something a HIE (health information exchange) cannot do. Blockchain technology’s potential impact on the life sciences industry (drugdevelopment, distribution and prescribing) is significant.
Wearable devices: These are devices that are worn on the body and can track health data such as heart rate, sleep, and activity levels. Telehealth: This is the delivery of healthcare services remotely, using technology such as video conferencing or phone calls. Examples include telehealth, e-prescriptions, and patient portals.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content